Evidence map›Paper›PMID 23616783›Full record

ArticleFrontiers in microbiology2013

β-1,3-glucan modifying enzymes in Aspergillus fumigatus.

Isabelle Mouyna, Lukas Hartl, Jean-Paul Latgé

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
10.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Functional and molecular characterization ofJournal of medical microbiology · 2026
    Article
  4. DVL, a Lectin fromAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Identification of Sesamin fromMolecules (Basel, Switzerland) · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Predication of the Effector Proteins Secreted byJournal of fungi (Basel, Switzerland) · 2022
    Article
  19. GH-16 Type β-1,3-Glucanase fromJournal of applied glycoscience · 2022
    Article
  20. Paeonol Disrupts the Integrity ofFoods (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Isabelle MouynaUnité des Aspergillus, Département de Parasitologie et Mycologie, Institut Pasteur Paris, France.
Lukas Hartl
Jean-Paul Latgé
Institut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Aspergillus fumigatus like in other filamentous ascomycetes, β-1,3-glucan constitutes a prominent cell wall component being responsible for rigidity of the cell wall structure. In filamentous fungi, softening of the cell wall is absolutely required during conidial germination and hyphal branching. Because of the central structure of β-1,3-glucans, it is expected that β-1,3-glucanases play a major role in cell wall softening. Based on in silico and experimental data, this review gives an overview of β-1,3-glucan modifying enzymes in A. fumigatus genome and their putative role during morphogenesis.

Indexed as

Aspergillus fumigatuscell wallendo-β-1,3-glucanaseexo-β-1,3-glucanaseβ-1,3-glucanβ-1,3-glucan modifying enzyme

Identifiers

PMID23616783
PMCPMC3627985
OpenAlexW1981895561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.